Huang SH, O´Sullivan B. Oral cancer: Current role of radiotherapy and
chemotherapy. Med Oral Patol Oral Cir Bucal. 2013
Mar 1;18 (2):e233-40.
doi:10.4317/medoral.18772
http://dx.doi.org/doi:10.4317/medoral.18772
|
1. Bessell A, Glenny
AM, Furness S, Clarkson JE, Oliver R, Conway DI, et al. Interventions for the
treatment of oral and oropharyngeal cancers:
surgical treatment. Cochrane Database Syst Rev. 2011;9:CD006205. |
|
|
|
|
|
2. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally
advanced head and neck cancers: a comparative analysis of concurrent
postoperative radiation plus chemotherapy trials of the EORTC (#22931) and
RTOG (# 9501). Head Neck.
2005;27:843-50. |
|
|
|
|
|
3. Cooper JS, Pajak TF, Forastiere
AA, Jacobs J, Campbell BH, Saxman SB, et al.
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-44. |
|
|
|
|
|
4. Shrime MG, Gullane
PJ, Dawson L, Kim J, Gilbert RW, Irish JC, et al. The impact of adjuvant
radiotherapy on survival in T1-2N1 squamous cell
carcinoma of the oral cavity. Arch Otolaryngol Head
Neck Surg. 2010;136:225-8. |
|
|
|
|
|
5. Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, et al. Evaluation of the dose for
postoperative radiation therapy of head and neck cancer: first report of a
prospective randomized trial. Int J Radiat Oncol Biol Phys. 1993;26:3-11. |
|
|
|
|
|
6. Langendijk JA, Slotman
BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive
partitioning analysis of patients with squamous
cell head and neck carcinoma treated with surgery and postoperative
radiotherapy. Cancer. 2005;104:1408-1417. |
|
|
|
|
|
7. Brown JS, Shaw RJ, Bekiroglu F, Rogers
SN. Systematic review of the current evidence in the use of postoperative
radiotherapy for oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2012;50:481-489. |
|
|
|
|
|
8. Huang
TY, Hsu LP, Wen YH, Huang TT, Chou YF, Lee CF, et
al. Predictors
of locoregional recurrence in early stage oral
cavity cancer with free surgical margins. Oral
Oncol. 2010;46:49-55. |
|
|
|
|
|
9. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh
C, Lee LY, et al. Does adjuvant radiation therapy improve outcomes in pT1-3N0
oral cavity cancer with tumor-free margins and perineural
invasion? Int J Radiat Oncol Biol Phys. 2008;71:371-6. |
|
|
|
|
|
10. Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B.
Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a
meta-analysis of reported studies. Cancer.
2009;115:1489-1497. |
|
|
|
|
|
11. Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, et al.
Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease. Int J Radiat Oncol Biol Phys. 2012;82:284-90. |
|
|
|
|
|
12. Moergel M, Jahn-Eimermacher
A, Krummenauer F, Reichert TE, Wagner W, Wendt TG,
et al. Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous
cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a
prospective multicenter randomized controlled clinical trial using a
comprehensive cohort design. Trials.
2009;10:118. |
|
|
|
|
|
13. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefčbvre JL, Greiner RH, et al.
Postoperative irradiation with or without concomitant chemotherapy for
locally advanced head and neck cancer. N Engl J
Med. 2004;350:1945-52. |
|
|
|
|
|
14. Cooper JS, Pajak TF, Forastiere
A, Jacobs J, Fu KK, Ang KK, et al. Precisely
defining high-risk operable head and neck tumors based on RTOG #85-03 and
#88-24: targets for postoperative radiochemotherapy?
Head Neck.1998;20:588-94. |
|
|
|
|
|
15. Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, et al.
Treatment results of postoperative radiotherapy on squamous
cell carcinoma of the oral cavity: coexistence of multiple minor risk factors
results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 2010;77:1024-9. |
|
|
|
|
|
16. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh
C, Lee LY, et al. Analysis of risk factors of predictive local tumor control
in oral cavity cancer. Ann Surg Oncol. 2008;15:915-22. |
|
|
|
|
|
17. Parsons JT, Mendenhall WM, Stringer SP, Cassisi
NJ, Million RR. An analysis of factors influencing the outcome of
postoperative irradiation for squamous cell
carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys. 1997;39:137-48. |
|
|
|
|
|
18. Looser KG, Shah JP, Strong EW. The significance of
"positive" margins in surgically resected
epidermoid carcinomas. Head Neck Surg. 1978;1:107-111. |
|
|
|
|
|
19. Batsakis JG. Surgical excision margins: a pathologist's
perspective. Adv Anat Pathol.
1999;6:140-148. |
|
|
|
|
|
20. Binahmed A, Nason
RW, Abdoh AA. The clinical significance of the
positive surgical margin in oral cancer. Oral
Oncol. 2007;43:780-784. |
|
|
|
|
|
21. Chen PY, Chen HH, Hsiao JR, Yang MW, Hsueh
WT, Tasi ST, et al. Intensity-modulated
radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2012;48:747-52. |
|
|
|
|
|
22. Guillemaud JP, Patel RS, Goldstein DP,
Higgins KM, Enepekides DJ. Prognostic impact of intraoperative microscopic cut-through on frozen section
in oral cavity squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2010;39:370-7. |
|
|
|
|
|
23. Huang J, Barbera L, Brouwers
M, Browman G, Mackillop
WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A
systematic review. J Clin Oncol.
2003;21:555-63. |
|
|
|
|
|
24. Daly ME, Le QT, Kozak MM, Maxim PG,
Murphy JD, Hsu A, et al. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and
predictors of local control. Int J Radiat Oncol Biol Phys. 2011;80:1412-22. |
|
|
|
|
|
25. Langendijk JA, de Jong
MA, Leemans CR, de Bree
R, Smeele LE, Doornaert
P, et al. Postoperative radiotherapy in squamous
cell carcinoma of the oral cavity: the importance of the overall treatment
time. Int J Radiat Oncol Biol Phys. 2003;57:693-700. |
|
|
|
|
|
26. Studer G, Zwahlen
RA, Graetz KW, Davis BJ, Glanzmann
C. IMRT in oral cavity cancer. Radiat Oncol. 2007;2:16. |
|
|
|
|
|
27. Murthy
V, Agarwal JP, Laskar SG,
Gupta T, Budrukkar A, Pai P, et al. Analysis of prognostic factors in 1180
patients with oral cavity primary cancer treated with definitive or adjuvant
radiotherapy. J Cancer
Res Ther. 2010;6:282-9. |
|
|
|
|
|
28. Cohen EE, Baru J, Huo
D, Haraf DJ, Crowley M, Witt ME, Blair EA, Weichselbaum RR, Rosen F, Vokes
EE, Stenson K. Efficacy and safety of treating T4
oral cavity tumors with primary chemoradiotherapy. Head Neck. 2009;31:1013-21. |
|
|
|
|
|
29. Pignon JP, le Maître A, Maillard E, Bourhis J. MACH-NC
Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer
(MACH-NC): an update on 93 randomised trials and
17,346 patients. Radiother Oncol. 2009;92:4-14. |
|
|
|
|
|
30. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M,
Bernier J, et al. Hyperfractionated or accelerated
radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843-54. |
|
|
|
|
|
31. Mazeron
JJ, Ardiet JM, Haie-Méder
C, Kovács G, Levendag P, Peiffert D, et al. GEC-ESTRO recommendations
for brachytherapy for head and neck squamous cell carcinomas. Radiother
Oncol. 2009;91:150-6. |
|
|
|
|
|
32. Chakrabarti
B, Ghorai S, Basu B, Ghosh SK, Gupta P, Ghosh K, et al. Late nodal metastasis in early-stage
node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in
India. Brachytherapy. 2010;9:254-9. |
|
|
|
|
|
33. Grabenbauer GG, Rödel
C, Brunner T, Schulze-Mosgau S, Strnad
V, Müller RG, et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment
of primary and recurrent cancer of the oral cavity and oropharynx.
Review of 318 patients treated between 1985 and 1997. Strahlenther
Onkol. 2001;177:338-44. |
|
|
|
|
|
34. Do L, Puthawala A, Syed
N. Interstitial brachytherapy as boost for locally
advanced T4 head and neck cancer. Brachytherapy. 2009;8:385-91. |
|
|
|
|
|
35. Patra NB, Goswami
J, Basu S, Chatterjee K, Sarkar SK. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in
head and neck cancer--an Indian (single institutional) learning experience. Brachytherapy. 2009;8:248-54. |
|
|
|
|
|
36. Chatani M, Tsuboi
K, Yagi M, Fujiwara K, Tachimoto
R, Yoshioka H. High dose rate brachytherapy using
molds after chemoradiotherapy for oral cavity
cancer. Jpn J Radiol. 2012;30:40-4. |
|
|
|
|
|
37. Lapeyre M, Bollet
MA, Racadot S, Geoffrois
L, Kaminsky MC, Hoffstetter
S, et al. Postoperative brachytherapy alone and
combined postoperative radiotherapy and brachytherapy
boost for squamous cell carcinoma of the oral
cavity, with positive or close margins. Head
Neck. 2004;26:216-23. |
|
|
|
|
|
38. Grimard L, Esche
B, Lamothe A, Cygler J, Spaans J. Interstitial low-dose-rate brachytherapy
in the treatment of recurrent head and neck malignancies. Head Neck. 2006;28:888-95. |
|
|
|
|
|
39. Grimard L, Esche
B, Lamothe A, Spaans JN.
Interstitial brachytherapy in the management of
persistent head and neck disease after definitive external beam radiation
therapy. Brachytherapy. 2009;8:284-9. |
|
|
|
|
|
40. Mazeron JJ, Noël G, Simon JM. Head and
neck brachytherapy. Semin
Radiat Oncol. 2002;12:95-108. |
|
|
|
|
|
41. Huang SF, Cheng SD, Chien HT, Liao CT,
Chen IH, Wang HM, et al. Relationship between epidermal growth factor
receptor gene copy number and protein expression in oral cavity squamous cell carcinoma. Oral Oncol. 2012;48:67-72. |
|
|
|
|
|
42. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ.
Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid
prevalent area cancer prognosis. Br J Cancer. 2003;89:681-6. |
|
|
|
|
|
43. Wheeler S, Siwak DR, Chai
R, LaValle C, Seethala
RR, Wang L, et al. Tumor epidermal growth factor receptor and EGFR PY1068 are
independent prognostic indicators for head and neck squamous
cell carcinoma. Clin Cancer Res. 2012;18:2278-89. |
|
|
|
|
|
44. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM,
Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-78. 45.
Bhide SA, Ahmed M, Newbold
K, Harrington KJ, Nutting CM. The role of intensity
modulated radiotherapy in advanced oral cavity carcinoma. J Cancer Res Ther. 2012;8 Suppl
1:S67-71. |
|
|
|
|
|
46. Sher DJ, Thotakura
V, Balboni TA, Norris CM, Haddad RI, Posner MR, et
al. Treatment of oral cavity squamous cell
carcinoma with adjuvant or definitive intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;81:e215-22. |
|
|
|
|
|
47. Tsai CJ, Hofstede TM, Sturgis EM, Garden
AS, Lindberg ME, Wei Q, et al. Osteoradionecrosis
and radiation dose to the mandible in patients with oropharyngeal
cancer. Int J Radiat Oncol Biol Phys. 2013;85:415-20. |
|
|
|
|
|
48. Balogh JM, Sutherland SE. Osteoradionecrosis of the mandible: a review. J Otolaryngol. 1989;18:245-50. |
|
|
|
|
|
49. Monnier Y, Broome M, Betz M, Bouferrache K, Ozsahin M, Jaques B. Mandibular osteoradionecrosis in squamous
cell carcinoma of the oral cavity and oropharynx:
incidence and risk factors. Otolaryngol Head Neck Surg. 2011;144:726-32. |
|
|
|
|
|
50. O'Sullivan B, Rumble RB, Warde P,
Members of the IMRT Indications Expert Panel. Intensity-modulated
radiotherapy in the treatment of head and neck cancer. Clin
Oncol (R Coll Radiol). 2012;24:474-87. |
|
|
|
|
|
51. Ben-David MA, Diamante M, Radawski JD,
Vineberg KA, Stroup C, Murdoch-Kinch CA, et al.
Lack of osteoradionecrosis of the mandible after
intensity-modulated radiotherapy for head and neck cancer: likely
contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68:396-402. |
|
|
|
|
|
52. Studer G, Studer
SP, Zwahlen RA, Huguenin
P, Grätz KW, Lütolf UM,
et al. Osteoradionecrosis of the mandible:
minimized risk profile following intensity-modulated radiation therapy
(IMRT). Strahlenther Onkol. 2006;182:283-8. |
|
|
|
|
|
53. Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, et al. Reducing xerostomia
after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
Int J Radiat Oncol Biol Phys.
2012;83:1007-14. |
|
|
|
|
|
54. Chen WC, Hwang TZ, Wang WH, Lu CH, Chen CC, Chen CM, et al. Comparison
between conventional and intensity-modulated post-operative radiotherapy for
stage III and IV oral cavity cancer in terms of treatment results and
toxicity. Oral Oncol. 2009;45:505-10.
55. Mishra RC, Singh DN, Mishra
TK. Post-operative radiotherapy in carcinoma of buccal
mucosa, a prospective randomized trial. Eur J Surg Oncol. 1996;22:502-4. |
|
|
|
|
55. Mishra RC, Singh DN, Mishra
TK. Post-operative radiotherapy in carcinoma of buccal
mucosa, a prospective randomized trial. Eur J Surg Oncol. 1996;22:502-4.
http://dx.doi.org/10.1016/S0748-7983(96)92969-8